Action on the Cerebral Vascular Endothelium in the Prevention of Stroke

*Andrés J. Ursa Herguedas and María Pellón Olmedo*

## **Abstract**

Stroke or cerebrovascular accident (CVA) is a frequent, disabling pathology, consumes enormous social and health resources and has high morbidity and mortality. A large part of the resources of the health systems are allocated to the treatment of stroke, which is achieving better results every time, and far fewer resources are allocated to prevention. The objective of this review is to raise awareness in the different states so that they allocate more resources to prevention through awareness programs for health personnel, and implementation of detection tests for atherosclerotic cardiovascular disease in order to reduce the incidence of stroke. Clients should be insisted on adopting an adequate lifestyle, as well as acting on risk factors. Most strokes can be prevented through health education, blood pressure control, and lifestyle changes such as eating a healthy diet, being physically active, and stopping smoking.

**Keywords:** prevention of stroke or cerebrovascular accident, atherosclerotic cardiovascular disease, endothelial dysfunction, cerebrovascular diseases, gut dysbiosis

## **1. Introduction**

Atherosclerotic cardiovascular disease (ACVD) is a chronic, generalized, and progressive pathology that modifies the arteries until it causes a cardiovascular event. Elevated low-density lipoproteins (LDL-C) in plasma over time is one of the main causes of this disease, along with other risk factors. Cardiovascular diseases are the leading cause of disability and death from middle ages of life in developed countries, in both sexes. Cerebrovascular disease (CVD) encompasses anatomoclinical entities caused by reduced blood supply in a certain vascular territory (ischemic-type CVD) or by rupture of an intracranial vessel (hemorrhagic-type CVD) [1].

One in six people in the world will suffer a stroke, representing the third cause of death in the West, being the first in women. In Europe, 1.3 million people suffer a stroke each year and it is the second most frequent cause of death. With about 25 million cases per year, acute ischemic stroke represents a major public health challenge worldwide [2, 3]. Strokes have increased globally in absolute terms, as well as associated deaths, partly due to the greater number of cases registered in low- and middle-income countries as well as the aging of the population [4]. In total, 90% of stroke cases can be correlated with behavioral factors, including poor diet, smoking, and little physical activity, as well as metabolic factors such as obesity, hypertension, and diabetes mellitus [5].

The four main noncommunicable diseases (NCDs), such as cardiovascular disease (including stroke), cancer, type 2 diabetes mellitus (DM2), and lung disease, share 4 risk factors: tobacco use, unhealthy diet, physical inactivity, and alcohol abuse. Therefore, from a public health perspective, mass actions on lifestyle factors are the most cost-effective means of NCD prevention [6]. In recent years, several studies have reported that alterations in the gut microbiota (GM) could be a risk factor for stroke [7, 8]. Vascular endothelial dysfunction (VED) presents with a loss of balance between the vasodilation and vasoconstriction factors derived from it, with a predominance of the latter, producing progressive pathophysiological changes that make it possible to cause proinflammatory, prooxidant, proliferative, and procoagulant effects and vascular adhesion, contributing to atherogenesis in each of its phases [9].

The prevention of ACVD in high-risk patients is one of the main challenges that healthcare professionals face in order to reduce the rates of morbidity and mortality from stroke.

Primary prevention refers to the adoption of a healthy lifestyle from an early age and secondary prevention refers to the implementation of measures aimed at acting on cardiovascular risk factors (CVRF).

## **2. Causal factors**

Ischemic infarcts are produced by the acute occlusion of one of the large cervical or cerebral arteries, either by a gradual narrowing of atherosclerotic origin or by a sudden occlusion produced by a thrombus (if it originates from the same cerebral arterial system) or an embolus (if the clot originates in a region of the vascular system other than the brain). In the case of hemorrhagic stroke, the rupture of a blood vessel occurs either at the intracerebral level (intracerebral hemorrhage) or by the rupture of aneurysms at the bifurcation of the great arteries on the surface of the brain (subarachnoid hemorrhage). Most strokes are ischemic (85%) and 15% hemorrhagic. A total of 15% of strokes occur in children [10, 11]. A small percentage of ACVD is related to genes [12].

Different studies demonstrated an association between elevated levels of total cholesterol and LDL-C and increased risk of ischemic stroke [13, 14]. A high intake of sugars, including added sugars and those naturally present in honey and fruit juices, is associated with an increased risk of developing cardiovascular diseases and, specifically, stroke [15]. In recent years, several studies have linked stroke with gut dysbiosis (GD) [16]. Although there are many causes of stroke, this chapter focuses on the prevention of ischemic strokes as they are the most frequent.

#### **3. Ischemic stroke risk factors**

Most strokes are due to modifiable risk factors, so there is a possibility of prevention. The main non-modifiable risk factor for stroke is age. In one-third of strokes, the cause is unknown [17].

**Table 1** contains the most frequent modifiable risk factors according to O'Donnell et al., [18], updated by the authors.

*Action on the Cerebral Vascular Endothelium in the Prevention of Stroke DOI: http://dx.doi.org/10.5772/intechopen.111669*


#### **Table 1.**

*Modifiable risk factors in stroke prevention according to O'Donnell et al., 2016 [18], updated by the authors.*

Arterial hypertension (AHT) is the main risk factor involved in cerebrovascular disease, both in ischemic and hemorrhagic strokes. GD has been observed in the prehypertensive state compared to a normotensive population. These changes precede the development of AHT and are not due to AHT itself [19]. Obesity increases the risk of suffering a stroke, especially abdominal fat. It is a public health problem because it is related to many diseases, among others, hypertension and DM2. Furthermore, the number of cases has increased greatly in recent years and has become an epidemic [20]. A sedentary lifestyle, as a cardiometabolic risk factor, contributes to the appearance of a stroke [21]. The cardiovascular risk in patients with obesity and DM2 is increased since it is generally accompanied by other cardiovascular risk factors such as AHT, hypercholesterolemia, hypertriglyceridemia, and metabolic syndrome (MS) among others [22, 23]. For several decades, numerous studies have linked the act of smoking with an increased risk of stroke. The related components are attributed to nicotine, oxidizing gases, and carbon monoxide. This risk also exists in passive smokers [24]. According to the 2016 Interstroke study, high and moderate alcohol intake is associated with an increased chance of suffering a stroke [18]. Prediabetes and DM2 are associated with increased vascular risk in parallel with the degree of hyperglycemia and the lack of good metabolic control. In patients with type 1 diabetes mellitus, the frequency of stroke is lower. Diabetics are at high risk of atherosclerosis and often have other atherogenic risk factors, such as AHT, hyperlipidemia, and obesity, known as MS [25]. The role of dyslipidemias, especially the elevation of total serum cholesterol, as well as LDL-C is a known factor in CVD that contributes to ischemic stroke [13, 14]. Established AHT is one of the most prevalent modifiable risk factors, being associated with more severe strokes and with a worse prognosis [26]. The causal relationship between GM and AHT is more evident when studying AHT secondary to obstructive sleep apnea syndrome [27]. The presence of a coagulopathy is a potential risk factor for a cardiovascular event, but another independent risk factor is

necessary, which acts by another mechanism to predispose to strokes, such as taking oral contraceptives, homocystinuria, etc. [28].

Associated with the aging process, there is a loss in the integrity of the intestinal epithelial barrier, a decrease in the number of enteric neurons and an increase in the synthesis of proinflammatory cytokines [29], factors possibly involved in the higher incidence of stroke from the average age of life.

#### **4. Role of the microbiota-gut-brain axis in cerebrovascular disease**

In the intestine, a series of products are generated by GM that exert their influence on the central nervous system (CNS), such as short-chain fatty acids (SCFAs), secondary bile acids, or tryptophan metabolites, which exert their function through ascending signals that start locally, either by crossing the intestinal barrier to pass into the systemic circulation or even acting directly in the CNS by crossing the bloodbrain barrier [30]. Microbial products that reach systemic circulation are capable of modulating the immune system toward a more inflammatory environment or inducing tolerance, both locally and in the CNS. A central role in this modulation is exerted through the products generated by the metabolism of dietary components, such as dietary fiber, tryptophan, or arginine, which give rise to polyamines, indoles, and SCFA, which are capable of increasing the expansion of regulatory T lymphocytes, favoring an antiinflammatory phenotype in dendritic cells and decreasing the production of proinflammatory cytokines in neutrophils and macrophages. Another mechanism that GM also uses to regulate the immune response is the modification of the host's own metabolites, in the case of secondary bile acids that regulate dendritic cells, macrophages, and natural killer cells, or through metabolites produced by intestinal bacteria, such as polysaccharide A from Bacteroides fragilis, with an antiinflammatory effect, or those produced by segmented filamentous bacteria, with a proinflammatory effect [31]. On the other hand, a correlation has been found between the increased risk of stroke and a greater burden of opportunistic pathogens, together with low levels of butyrate-producing intestinal bacteria [32]. Recent studies in animal models and later in human fecal samples after suffering an ischemic stroke compared to a control group have linked a certain GM with a higher risk of suffering a stroke, so it would become a modifiable risk factor [33]. Currently, the actions of microorganisms are beginning to be assessed as risk factors, such as infections caused by Chlamydia pneumoniae and Helicobacter pylori, reactivation of the varicellazoster virus, etc. [34].

Within the actions of the microbiota-gut-brain axis (MGBA), through the vagus nerve, different microbial metabolites are detected and are capable of generating responses at the central level, as well as producing cholinergic responses secondary to peripheral inflammation, which translate into alterations in intestinal permeability and modulation of GM composition [35]. Among the environmental factors that increase intestinal permeability are alcohol consumption, prolonged use of antibiotics, abuse of non-steroidal antiinflammatory drugs, food allergies, radiation, and chemotherapy. Another group is made up of artificial sweeteners, such as aspartame and sucralose, pesticides, some household detergents, environmental pollutants, gluten in celiac patients, and the consumption of some marine fish that concentrate heavy metals [36, 37]. Under certain circumstances, GM can become unbalanced and favor the expansion of pathobiont microorganisms, organisms of the GM that are harmless under normal conditions but with infectious capacity in certain states [38], which

#### *Action on the Cerebral Vascular Endothelium in the Prevention of Stroke DOI: http://dx.doi.org/10.5772/intechopen.111669*

can alter the entire host immune response and increase permeability of bowel [37]. Large uncharged molecules, such as proteins or lipopolysaccharides, or large charged molecules can pass through the tight junctions between epithelial cells [39]. However, deregulation of these junctions as a result of genetic or environmental factors, such as diet, drug use, or the activity of pathogenic microorganisms, can cause increased intestinal permeability. This phenomenon is frequently observed in inflammatory bowel diseases and in some metabolic diseases, such as diabetes or obesity [40]. In murine models, it has been observed that GM is a factor that can significantly influence the genesis of stroke [41]. SCFAs are an important class of bacterial metabolites that are obtained from the fermentation of polysaccharides (fibers) [42]. Preliminary studies showed that SCFAs have an important role in maintaining intestinal integrity and have an antiinflammatory effect [43]. One of the SCFAs, butyrate, is a preferential energy source for intestinal epithelial cells, thus contributing to their physiology [44]. SCFAs can reach the brain, due to the presence of transporters of these molecules in the endothelial cells of the blood-brain barrier [45]. Once there, they can modulate neuroinflammation by acting on the morphology and activation of microglia in the event of stroke [45].

GM can generate potentially toxic compounds, such as the formation of trimethylamine from choline and carnitine present in the diet [46]. Trimethylamine is absorbed and transformed into trimethylamine N-oxide (TMAO) in the liver, being considered a risk factor for cardiovascular disease [47].

These mechanisms may partly explain the factors dependent on the human microbiome that may favor stroke.

### **5. Role of the vascular endothelium**

Endothelial cells (ECs) are capable of detecting physical changes related to mechanical stress caused by blood flow, blood pressure, or wall distension. When an imbalance occurs in the bioavailability of vasoactive substances, the predisposition to platelet aggregation, thrombosis, inflammation, vasoconstriction, or increased vascular permeability, a situation called vascular endothelial dysfunction (VED), occur.

VED is one of the initial events of atherosclerosis, it plays a fundamental role in ACVD and, therefore, in CVD [48]. GM has the ability to produce metabolites that directly affect the host's cardiovascular system, being able to generate antagonistic effects (pro- and antiinflammatory, vasodilator, and vasoconstrictor) with both beneficial and harmful results. These metabolites include SCFA, TMAO, nitrites, indoles, and hydrogen sulfide. In AHT models, it has been shown that there is a decrease in the intestinal bacterial populations that produce SCFA and hydrogen sulfide (both with vasodilator properties). At the other extreme, TMAO-type metabolites, as well as indoles, would favor arterial vasoconstriction [49]. In experimental animals, it has been possible to induce atherosclerotic lesions similar to those found in human arteries, through the administration of diets rich in cholesterol and saturated fat. This type of diet produces an increase in plasma LDL-C concentrations and facilitates its accumulation in the subendothelial space in areas where permeability is increased. In these models, it has been observed that the regions most prone to developing atherosclerotic lesions present a greater permeability to LDL-C and very low-density lipoproteins (VLDL) [50]. It has been observed that high concentrations of native LDL-C and low concentrations of oxidized LDL-C increase vascular permeability since they reduce the content of heparan sulfate proteoglycans in the extracellular matrix of the

subendothelial space. This effect would be produced by a negative regulation of the synthesis of these molecules, as well as an increase in their degradation thanks to the induction of endothelial secretion of heparanase [51].

VED is characterized by an imbalance between the relaxation and contraction factors derived from the endothelium [52] and is both the cause and effect of atherosclerotic lesions in cerebral arteries [53]. In SARS-Cov-2 infection, thrombotic complications are frequent and severe. Loss of even a small number of endothelial cells due to infection could lead to a breakdown of the endothelial barrier, resulting in "vascular leakage," thus exposing inflammatory cells. This would lead to an abnormal activation of the coagulation system that would cause inflammation of small vessels and microthrombi, which could affect the heart, lungs, or brain [54].

Numerous factors and markers of endothelial damage have been studied, which turn out to be predictors of an advance in the development of atherosclerotic plaque and, therefore, of its instability. The quantification of the degree of vasodilation mediated by hyperflow (VMH) of the brachial artery is a noninvasive, cheap, simple, reproducible, readily available, and validated ultrasonographic technique that allows us to know the state of health and function of the vascular endothelium. It is a response dependent on endothelial nitric oxide and, when it is decreased, translates to a VED. VMH is reduced in patients with vascular risk factors, cerebral, coronary, or peripheral vascular disease, and is an independent predictor of vascular events and vascular recurrence. It also allows us to be able to detect and quantify the degree of VED early, anticipating the appearance of atheromatous plaque. VED improves with various drugs, such as antihypertensives, antidiabetics, antiaggregants, or lipidlowering agents [55].

#### **6. Precautionary measures**

Stroke is a disease that, to a large extent, can be avoided. Therefore, identifying the risk factors of each person is key to drawing up a preventive strategy at the individual level. The scope of action to carry out these activities is primary health care. A healthy lifestyle can reduce the risk of cardiovascular events. Most strokes can be prevented with hygienic-dietary habits. For this, modifiable risk factors must be monitored, such as obesity/overweight, sedentary lifestyle, smoking, alcohol abuse, AHT, dyslipidemia, DM2, and previous heart disease. There are cardiovascular risk factors that cannot be modified, such as age, sex, family history, thrombophilia, and previous strokes. It is necessary to carry out awareness campaigns on stroke in preventive aspects. **Table 2** contains the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Diabetes Society (SED, 2014–2015) [22].

Eating a healthy diet, rich in plant-based foods, can help modify IM so that the production of deleterious metabolites such as TMAO is reduced [56]. Plant-based diets are associated with significant benefits in the improvement or prevention of metabolic diseases (overweight, obesity, DM2), cardiovascular disease, inflammatory bowel disease, and chronic kidney disease. In addition, a very important emerging aspect, in which the evidence is growing, is the beneficial effect on aging and aspects linked to it, such as sarcopenia [57, 58]. Proteins, carbohydrates, and fats present in plant foods can shift the GM profile toward increased production of antiinflammatory compounds and decreased production of endogenous toxins. Vegetable fats, particularly olive oil, are antiinflammatory and antiatherogenic [21].


#### **Table 2.**

*Recommendations of the diabetes and cardiovascular disease working group (SED, 2014–2015), adapted by the authors of the chapter.*

Moderate-intensity physical exercise, such as walking or cycling, should be part of daily activity in healthy adults [59, 60]. Keeping your weight within healthy limits is very important for the normal functioning of the heart, blood vessels, metabolism, bones, and other organs. All this happens to maintain a balance between the calories that are ingested. A balanced diet, physical exercise, and in some cases drugs can help achieve this goal. Glycemic control, especially in predisposed patients, is an important factor in order to prevent the complications of DM2. Various antidiabetic drugs may play an important role in stroke prevention [61]. The management of dyslipidemias is based on implementing healthy lifestyle habits and pharmacological treatment. The indication to start lipid-lowering treatment will depend on the vascular risk of each subject. Statins are the drugs of choice. Other effective lipid-lowering agents are ezetimibe combined with statins and PCSK9 (protein convertase subtilisin-kexin type 9) inhibitors. Other drugs such as fibrates or omega-3 fatty acids are useful in the management of triglycerides, although their usefulness in the prevention of vascular diseases is not well defined [62, 63]. Reducing blood pressure is the key, both in the primary prevention of the disease and in the secondary to avoid its recurrence. It is recommended to start antihypertensive treatment for primary prevention of stroke in patients with blood pressure figures higher than 140/90 mmHg [26]. Anticoagulants

are recommended in case of atrial fibrillation in any patient over 75 years of age and with several CVRFs [64].

In stroke prevention campaigns, emphasis must be placed on the importance of rapid action in the event of a stroke. Hospitals have protocols (stroke code) for early diagnosis with imaging tests using artificial intelligence and early treatment in order to minimize neurological damage. Having suffered a stroke is a risk factor for suffering it again. For this reason, secondary prevention, the adoption of good lifestyle habits, and good adherence to prescribed treatments are essential [65]. Once the sequelae of the stroke have been assessed early, both physical (speech therapy and physiotherapy) as well as social and psychological rehabilitation begins after 48–72 hours. The idea is to go to a neurorehabilitation unit. The objective is for the patient to remain independent and autonomous for the basic and instrumented activities of daily life. Between 40 and 50% of patients abandon treatment 2 or 3 years after having suffered a stroke, which favors the appearance of a second event, the repercussion of which will be worse than that of the first [66]. Biomarkers that predict stroke outcome include serum triglyceride level, HDL-cholesterol [67], interleukin-6 (IL-6), NT-proBNP [68], and YKL-40 [69]. IM modulation, especially with prebiotics and/or probiotics, represents a preventive and therapeutic approach to take into account in the approach to ACVD [70].

## **7. Conclusions**


## **Acknowledgements**

The chapter has been funded by the Institute for Integrative Medicine.

## **Conflict of interest**

There is no conflict of interest.

*Action on the Cerebral Vascular Endothelium in the Prevention of Stroke DOI: http://dx.doi.org/10.5772/intechopen.111669*

## **Abbreviations**


## **Author details**

Andrés J. Ursa Herguedas1,2,3,4,5,6,7\* and María Pellón Olmedo8,9,10,11,12,13,14

Institute of Integrative Medicine, Valladolid, Spain

Complutense University of Madrid, Madrid, Spain

Junta de Castilla y León, Valladolid, Spain

Rehabilitation and Pain from the University of Valladolid, Spain

Clinical Neurophysiology from the University of Valladolid, Spain

Academy of Health Sciences Dr. Ramón y Cajal, Madrid, Spain

Dr. Gómez Ulla Award for Health Excellence, Madrid, Spain

Pharmacy from the University of Salamanca, Spain

Human Nutrition and Dietetics from the University of Valladolid, Spain

Pharmacy from the University of Valladolid, Spain

University and Non-University Education (health area), Spain

Pharmaceutical Care from the University of Valencia, Spain

Orthopedics and Technical Aids from the University of Salamanca, Spain

 CESME (Faculty of Medicine of Valladolid) and of the SEFAC Nutrition Group, Spain

\*Address all correspondence to: ajursa@educa.jcyl.es

© 2023 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

*Action on the Cerebral Vascular Endothelium in the Prevention of Stroke DOI: http://dx.doi.org/10.5772/intechopen.111669*

## **References**

[1] Torregrosa G et al. Basic pathophysiology: From arterial occlusion to neuronal death. In: Montaner J, editor. Pathophysiology of Cerebral Ischemia. Barcelona, Spain: ICG Marge. SL; 2007. pp. 13-31

[2] Purroy F, Montalá N. Epidemiology of stroke in the last decade. Neurology Journal. 2021;**73**(9):321-336. DOI: 10.33588/rn.7309.2021138

[3] Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circulation Research. 2017;**120**(3):439-448. DOI: 10.1161/CIRCRESAHA.116.308413

[4] Katan M, Luft A. Global burden of stroke. Seminars in Neurology. 2018;**38**(02):208-211. DOI: 10.1055/s-0038-1649503

[5] Hernández Ruiz de Eguilaz M, Batlle MA, Martínez de Morentin B, San-Cristóbal R, Pérez-Díez S, Navas-Carretero S, et al. Dietary and lifestyle changes as a strategy in the prevention of metabolic syndrome and type 2 diabetes mellitus: Milestones and perspectives. Annals of the Navarrese Health System. 2016 (cited 2023 Mar 27);**39**(2):269-289 Available from: http://scielo.isciii.es/scielo. php?script=sci\_arttext&pid=S1137- 66272016000200009&lng=es

[6] Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the noncommunicable disease crisis. Lancet. 2011;**377**(9775):1438-1447. DOI: 10.1016/ S0140-6736(11)60393-0

[7] Li H, Zhang X, Pan D, Liu Y, Yan X, Tang Y, et al. Dysbiosis characteristics of gut microbiota in cerebral infarction patients. Translational Neuroscience.

2020;**11**(1):124-133. DOI: 10.1515/tnsci-2020-6117. Available from: https://www. degruyter.com/document/doi/10.1515/ tnsci-2020-0117/html

[8] Rodríguez Perón JM, Rodríguez Izquierdo MM. Bioactive metabolites generated by intestinal dysbiosis and their pathophysiological implications in cardiovascular disease. Revista Cubana de Medicina. 2022;**61**(1):e2584 Available from: http://scielo.sld.cu/scielo. php?script=sci\_arttext&pid=S0034- 75232022000100013&lng=es

[9] Carvajal Carvajal C. The endothelium: Structure, function and endothelial dysfunction. Legal Medicine of Costa Rica. virtual edition. 2017;**34**(2):90-100 ISSN 2215-5287

[10] Diez-Tejedor E, del Brutto O, Alvarez Sabin J, et al. Classification of cerebrovascular diseases. Iberoamerican Society of Cerebrovascular Diseases Neurology Magazine. 2001;**33**:455-456. DOI: 10.33588/rn.3305.2001246

[11] Sobrino García P, García Pastor A, García Arratibel A, Vicente Peracho G, Rodríguez Cruz PM, Pérez Sánchez JR, et al. Etiological classification of ischemic stroke: Comparison between the new A-S-C-O classification and the classification of the study Group of Cerebrovascular Diseases of the Spanish Society of Neurology. Neurology. 2013;**28**(7):417- 424. DOI: 10.1016/j.nrl.2012.07.005

[12] Chauhan G, Debette S. Genetic risk factors for ischemic and hemorrhagic stroke. Current Cardiology Reports. 2016;**18**(12):124. DOI: 10.1007/ s11886-016-0804-z

[13] Yaghi S, Elkind MS. Lipids and cerebrovascular disease. Research and Practice. Stroke. 2015;**46**:3322-3328. DOI: 10.1161/estrokeaha.115.011164

[14] Lee JS, Chang PY, Zhang Y, Kizer JR, Best LG, Howard BV. Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: The strong heart study. Diabetes Care. 2017;**40**(4):529-537. DOI: 10.2337/ dc16-1958

[15] Kelly RK et al. Associations between types and sources of dietary carbohydrates and cardiovascular disease risk: A prospective cohort study of UK biobank participants. BMC Medicine. 2023;**21**:34. DOI: 10.1186/ s12916-022-02712-7

[16] Zeng X, Gao X, Peng Y, Wu Q, Zhu J, Tan C, et al. Higher risk of stroke is correlated with increased opportunistic pathogen load and reduced levels of butyrate-producing bacteria in the gut. Frontiers in Cellular and Infection Microbiology. 2019;**9**:4. DOI: 10.3389/ fcimb.2019.00004

[17] O'Donnell MJ, Javier D, Liu L, et al. Risk factors for intracerebral and ischemic hemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study. Lancet. 2010;**376**:112-123. DOI: 10.1016/ S0140-6736(10)60834-3

[18] O'Donnell MJ et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. Lancet. 2016;**388**:761-775. DOI: 10.1016/ S0140-6736(16)30506-2

[19] Arredondo Bruce A, Guerrero Jiménez G, Arredondo RA. Relationship between intestinal microbiota and blood pressure. MEDISAN. 2019;**23**(5):967-980 Available from: http://scielo.sld.cu/scielo.

php?script=sci\_arttext&pid=S1029- 30192019000500967&lng=es

[20] Rodríguez-Campello A, Jiménez-Conde J, Ois Á, Cuadrado-Godia E, Giralt-Steinhauer E, Vivanco RM, et al. Sex-related differences in abdominal obesity impact on ischemic stroke risk. European Journal of Neurology. 2016;**24**(2):1-7. DOI: 10.1111/ene.13216

[21] Arocha RJI. Cardiometabolic risk of sedentary lifestyle. Clinical Hospital University of Chile Magazine. 2023;**32**(3) Retrieved from: https:// revistahospitalclinico.uchile.cl/index. php/RHCUC/article/view/69536

[22] Arrieta F et al. Diabetes mellitus and cardiovascular risk: Recommendations of the diabetes and cardiovascular disease working Group of the Spanish Diabetes Society (SED, 2015). Primary Care. 2016;**48**(5):325-336. DOI: 10.1016/j. aprim.2015.05.002

[23] Muñoz Roldán I, Martín Puig M, Agudo Villa M, Recarte García C, Millán J. Cardiovascular risk in type 2 diabetic patients with or without associated metabolic syndrome. Clinic and research in arteriosclerosis. 2011;**23**(3):112-118. DOI: 10.1016/j. arteri.2011.03.002

[24] Bonita R, Scragg R, Stewart A, Jackson R, Beaglehole R. Cigarette smoking and risk of premature stroke in men and women. British Medical Journal (Clinical Research Ed.). 1986;**293**(6538):6- 8. DOI: 10.1136/bmj.293.6538.6

[25] Fuentes B et al. Stroke prevention in patients with type 2 diabetes mellitus or prediabetes. Recommendations of the study Group of Cerebrovascular Diseases of the Spanish Society of Neurology. Neurology. 2021;**36**(4):305-323. DOI: 10.1016/j.nrl.2020.04.030

*Action on the Cerebral Vascular Endothelium in the Prevention of Stroke DOI: http://dx.doi.org/10.5772/intechopen.111669*

[26] Rodríguez-Yañez M et al. Prevention of stroke in patients with arterial hypertension: Recommendations of the study Group of Cerebrovascular Diseases of the Spanish Society of Neurology. Neurology. 2021;**36**(6):462-471. DOI: 10.1016/j.nrleng.2020.04.023

[27] Durgan DJ, Ganesh BP, Cope JL, Ajami NJ, Phillips SC, Petrosino JF, et al. Role of the gut microbiome in obstructive sleep apnea-induced hypertension. Hypertension. 2016;**67**:469-474. DOI: 10.1161/ hipertensionaha.115.06672

[28] Sánchez Álvarez MJ. Epidemiology and causes of cerebral vascular disease in children. Spanish Journal of Pediatrics. 2017;**73**(Suppl 1):4 ISSN 0034-947X

[29] Spychala MS, Venna VR, Jandzinski M, Doran SJ, Durgan DJ, Ganesh BP, et al. Age-related changes in the gut microbiota influence systemic inflammation and stroke outcome. Annals of Neurology. 2018;**84**(1):23-36. DOI: 10.1002/ana.25250

[30] Osadchiy V, Martin CR, Mayer EA. The gut-brain axis and the microbiome: Mechanisms and clinical implications. Clinical Gastroenterology and Hepatology. 2019;**17**:322-332. DOI: 10.1016/j.cgh.2018.10.002

[31] Postler TS, Ghosh S. Understanding the holobiont: How microbial metabolites affect human health and shape the immune system. Cell Metabolism. 2017;**26**:110-130. DOI: 10.1016/j. cmet.2017.05.008

[32] Zeng X et al. Higher risk of stroke is correlated with increased opportunistic pathogen load and reduced levels of butyrate-producing bacteria in the gut. Frontiers in Cellular and Infection Microbiology. 2019;**9**(4):1-12. DOI: 10.3389/fcimb.2019.00004

[33] Lledós M. New Study Links Gut Microbiota Strains to more Severe Strokes and Poorer Post-Stroke Recovery Was Presented at the 8th European Stroke Organization Conference, Lyon, France: ESOC. May 4-6. 2022. Retrieved from: http://www.recercasantpau. cat/actualitat/un-estudi-relaciona-elmicrobioma-intestinal-amb-el-riscdictus-i-la-seva-evolucio/

[34] Saberi A, Akhondzadeh S, Kazemi S. Infectious agents and stroke: A systematic review. Basic and Clinical Neuroscience. 2021;**12**(4):427-440. DOI: 10.32598/bcn.2021.1324.2

[35] Bonaz B, Bazin T, Pellissier S. The vagus nerve at the interface of the microbiota-gut-brain axis. Frontiers in Neuroscience. 2018;**12**:49. DOI: 10.3389/ fnins.2018.00049

[36] Lerner A, Matthias T. Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmunity Reviews. 2015;**14**(6):479-489. DOI: 10.1016/j.autrev.2015.01.009

[37] Obrenovich M. Leaky gut, leaky brain? Microorganisms. 2018;**6**(4):107. DOI: 10.3390/microorganisms6040107

[38] Pérez-López A et al. Mucosal immunity to pathogenic intestinal bacteria. Nature Reviews Immunology. 2016;**16**(3):135-148. DOI: 10.1038/ nri.2015.17

[39] Dokladny K, Zuhl MN, Moseley PL. Intestinal epithelial barrier function and tight junction proteins with heat and exercise. Journal of Applied Physiology. 2016;**120**(6):692-701. DOI: 10.1152/ japplphysiol.00536.2015

[40] Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Experimental & Molecular Medicine. 2018;**50**(8):1-9. DOI: 10.1038/ s12276-018-0126-x

[41] Houlden A. Brain injury induces specific changes in the cecal microbiota of mice through altered autonomic activity and mucoprotein production. Brain, Behavior, and Immunity. 2016;**57**:10-20. DOI: 10.1016/j. bbi.2016.04.003

[42] Cummings, Pomare EW, Branch WJ, Naylos CP, Macfarlane GT. Short-chain fatty acids in the human large intestine, portal, hepatic, and venous blood. Intest. 1987;**28**(10):1221-1227. DOI: 10.1136/ gut.28.10.1221

[43] Koh A et al. From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell. 2016;**165**(6):1332-1345. DOI: 10.1016/j. cell.2016.05.041

[44] Zheng L et al. Microbe-derived butyrate promotes epithelial barrier function through IL-10 receptordependent Claudin-2 repression. Journal of Immunology. 2017;**199**(8):2976-2984. DOI: 10.4049/jimmunol.1700105

[45] Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of shortchain fatty acids in microbiota-gut-brain communication. Nature Reviews. Gastroenterology & Hepatology. 2019;**16**(8):461-478. DOI: 10.1038/ s41575-019-0157-3

[46] Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nature Medicine. 2013;**19**:576-585. DOI: 10.1038/ nm.3145

[47] Tang WHW, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. The New England Journal of Medicine. 2013;**368**:1575-1584. DOI: 10.1056/NEJMoa1109400

[48] Drexler H. Endothelial dysfunction: Clinical implication. Progress in Cardiovascular Diseases. 1997;**4**:287-324. DOI: 10.1016/s0033-0620(97)80030-8

[49] Zoetendal EG, Smidt H. Endothelial dysfunction: What is the role of the microbiota? Gut. 2018;**67**(2):201-202. DOI: 10.1136/gutjnl-2017-314012

[50] Nordestgaard B, Nielsen L. Atherosclerosis and arterial influx of lipoproteins. Current Opinion in Lipidology. 1994;**5**:252-257. DOI: 10.1097/ 00041433-199408000-00002

[51] Pillarisetti S. Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (Perlecan) and atherogenicity. Trends in Cardiovascular Medicine. 2000;**10**:60-65. DOI: 10.1016/ s1050-1738(00)00048-7

[52] Torres Saura F, Romero Vazquiánez M, Pérez Berbel P, Cotilla de la Rosa E, Diez Ojea B, Arroyo ÚE. New approach to the prevention of stroke in patients with non-valvular fibrillation in hemodialysis: Percutaneous closure of left atrial appendage. Archivos de Cardiología de México. 2020;**90**(1):96-98 Available from: http://www.scielo.org.mx/pdf/acm/ v90n1/2604-7063-acm-90-1-96.pdf

[53] Romero Cortés I, Guzmán Morales AG, Islas Ruz FG. Successful thrombolysis in cerebrovascular disease: A case report. Revista de Sanidad Militar. 2018;**72**(5-6):359-362 Available from: http://www.scielo.org.mx/pdf/rsm/ v72n5-6/0301-696X-rsm-72-5-6-359.pdf

[54] Rodríguez C, Luque N, Blanco I, Sebastian L, Barberà JA, Peinado VI, et al. *Action on the Cerebral Vascular Endothelium in the Prevention of Stroke DOI: http://dx.doi.org/10.5772/intechopen.111669*

Pulmonary endothelial dysfunction and thrombotic complications in patients with COVID-19. American Journal of Respiratory Cell and Molecular Biology. 2021;**64**(4):407-415. DOI: 10.1165/ rcmb.2020-0359PS

[55] Santos García D, Rodríguez Yáñez M, Arias Rivas S, Blanco M. Endotheliumdependent vasodilation in the brachial artery: Use in clinical and experimental neurology. Neurology Journal. 2011;**53**(6):351-353. DOI: 10.33588/ rn,5306.2011240

[56] Roncal C, Martínez-Aguilar E, Orbe J, et al. Trimethylamine N-oxide (TMAO) predicts cardiovascular mortality in peripheral arterial disease. Scientific Reports. 2019;**9**:15580 Retrieved from: DOI: 10.1038/s41598-019-52082-z

[57] Orlich MJ, Singh PN, Sabaté J, Jaceldo-Siegl K, Fan J, Knutsen S, et al. Vegetarian dietary patterns and mortality in Adventist health study 2. JAMA Internal Medicine. 2013;**173**(13):1230-1238. DOI: 10.1001/jamainternmed.2013.6473

[58] Bechthold A, Boeing H, et al. Food groups and risk of coronary heart disease, stroke and heart failure: A systematic review and dose-response meta-analysis of prospective studies. Critical Reviews in Food Science and Nutrition. 2019;**59**(7):1071. DOI: 10.1080/10408398.2017.1392288

[59] Strath SJ, Kaminsky LA, Ainsworth ES, et al. Guide to physical activity assessment: Clinical and research applications: A scientific statement from the American Heart Association. Circulation. 2013;**128**:2259-2279. DOI: 10.1161/01.cir.0000435708. 67487.da

[60] Coutts SB, Wein TH, Lindsay MP, Buck B, Cote R, Ellis P, et al. Canadian stroke Best practice recommendations: Secondary prevention of stroke

guidelines, update 2014. International Journal of Stroke. 2015;**10**(3):282-291. DOI: 10.1111/ijs.12439

[61] Fuentes B. Antidiabetics in stroke prevention in patients with type 2 diabetes. The neurologist's point of view. Clinical Medicine. 2018;**150**(7):275-281. DOI: 10.1016/j.medcli.2017.09.012

[62] Palacio-Portilla EJ et al. Dyslipidemia and stroke prevention: Recommendations of the cerebrovascular disease study Group of the Spanish Society of neurology. Neurology. 2022;**37**(1):61-72. DOI: 10.1016/j. nrl.2020.07.027

[63] Verma S, Gulati P, Khatter H, et al. Secondary prevention process evaluation protocol using a structured semiinteractive stroke prevention package in the Indian study (SPRINT India). International Journal of Qualitative Methods. 2022; Retrieved from:. DOI: 10.1177/16094069221093139

[64] Kate MP, Verma SJ, Arora D, Sylaja PN, Padma MV, Bhatia R, et al. Systematic development of structured semi-interactive stroke prevention package for secondary stroke prevention. Annals of Indian Academy of Neurology. 2020;**23**(5):681-686. DOI: 10.4103/aian. AIAN\_639\_19

[65] Khatter H, Pandián JD, Kate M, et al. Statistical analysis plan for secondary prevention using structured semiinteractive stroke prevention package in INDIA (SPRINT INDIA): A randomized controlled trial. Med. International Journal Stroke 2022;**5**:14-20. DOI: 10.1177/1747493019895653

[66] Kamal AK, Jeque Q, Pachá O, et al. A randomized controlled trial of behavioral intervention to improve medication adherence in adult stroke patients with a prescription-tailored short message

service (SMS): SMS4 stroke study. BMC Neurology. 2015;**15**:212. DOI: 10.1186/ s12883-015-0471-5

[67] Deng QW et al. Triglyceride to high-density lipoprotein cholesterol ratio predicts worse outcomes after acute ischemic stroke. European Journal of Neurology. 2017;**24**(2):283-291. DOI: 10.1111/ene.13198

[68] Dieplinger B et al. Prognostic value of inflammatory and cardiovascular biomarkers for the prediction of 90-day all-cause mortality after acute ischemic stroke: Results of the Linz stroke unit study. Clinical Chemistry. 2017;**63**(6):1101-1109. DOI: 10.1373/ clinchem.2016.269969

[69] Chen XL et al. Serum YKL-40, a prognostic marker in patients with large-artery atherosclerotic stroke. Acta Neurologica Scandinavica. 2017;**136**(2):97-102. DOI: 10.1111/ ane.12688

[70] Tiwari P, Dwivedi R, Bansal M, Tripathi M, Dada R. Role of gut microbiota in neurological disorders and its therapeutic significance. Journal of Clinical Medicine. 2023;**12**(4):1650. DOI: 10.3390/jcm12041650

**Chapter 7**
